Invited ForewordsThe Evolution of Toolkits and Bundles to Improve the Care of Sepsis PatientsMartin, Greg S. MD, MSc, FCCM1,2; Kane-Gill, Sandra L. PharmD, MSc, FCCM3; Nadkarni, Vinay MD, FAAP, FAHA, FCCM4,5; Sorce, Lauren R. PhD, RN, CPNP-AC/PC, FCCM6,7; Kaplan, Lewis J. MD, FACS, FCCP, FCCM5,8; Cecconi, Maurizio MD, FRCA, FFICM MD(Res)9,10; Azoulay, Elie MD, PhD11,12; Teboul, Jean-Louis MD, PhD13,14; Forni, Lui BSc, PhD, MB.BS, MRCPI, AFICM15; Kesecioglu, Jozef MD, PhD16 Author Information 1 Emory University School of Medicine, Atlanta, GA. 2 Grady Memorial Hospital, Atlanta, GA. 3 University of Pittsburgh School of Pharmacy, Pittsburgh, PA. 4 Children’s Hospital of Philadelphia, Philadelphia, PA. 5 Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. 6 Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL. 7 Northwestern University, Feinberg School of Medicine, Chicago, IL. 8 Corporal Michael J Crescenz Veterans Administration Medical Center, Philadelphia, PA. 9 Department of Biomedical Sciences, Humanitas University Pieve Emanuele, Milan, Italy. 10 IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy. 11 Hôpital Saint-Louis, Paris, France. 12 Paris Diderot University, Paris, France. 13 University Paris-South, Paris, France. 14 Bicêtre University Hospital, Paris, France. 15 University of Surrey and Royal Surrey County Hospital, NHS Foundation Trust, Guildford, United Kingdom. 16 University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. Dr. Martin serves as president of the Society of Critical Care Medicine (SCCM). Drs. Kane-Gill, Nadkarni, Sorce, and Kaplan serve as members of the Society of Critical Care Medicine Executive Committee. Drs. Cecconi, Azoulay, Teboul, Forni and Kesecioglu serve as members of the ESICM Executive Committee. Drs. Martin, Kane-Gill, Cecconi, and Azoulay serve as members of the Surviving Sepsis Campaign Executive Committee. Dr. Kaplan received funding from SCCM. Dr. Cecconi received funding from Edwards Lifesciences and Directed Systems. Dr. Azoulay’s institution received funding from Fisher & Paykel, Jazz Pharma, MSD, and Alexion; he received funding from Pfizer, Sanofi, Alexion, and Gilead. Drs. Azoulay and Forni received funding from Baxter Medical. Dr. Teboul received funding from Getinge. Dr. Forni received funding from Exthera Medical and Biomerieux. The remaining authors have disclosed that they do not have any potential conflicts of interest. For information regarding this commentary email: [email protected]. Critical Care Medicine: November 2021 - Volume 49 - Issue 11 - p 1849-1850 doi: 10.1097/CCM.0000000000005356 Buy Metrics Copyright © 2021 by the Society of Critical Care Medicine. All Rights Reserved.